Literature DB >> 31041057

In search of new biomarkers for nonalcoholic fatty liver disease.

Ting-Ting Chan1, Vincent Wai-Sun Wong1.   

Abstract

Entities:  

Year:  2016        PMID： 31041057      PMCID： PMC6490188          DOI： 10.1002/cld.563

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  3 in total

1.  Machine learning using longitudinal prescription and medical claims for the detection of non-alcoholic steatohepatitis (NASH).

Authors:  Ozge Yasar; Patrick Long; Brett Harder; Hanna Marshall; Sanjay Bhasin; Suyin Lee; Mark Delegge; Stephanie Roy; Orla Doyle; Nadea Leavitt; John Rigg
Journal:  BMJ Health Care Inform       Date:  2022-03

Review 2.  Nonalcoholic Fatty Liver Disease: Could It Be the Next Medical Tsunami?

Authors:  Priyanka Bhandari; Amit Sapra; Mohitkumar S Ajmeri; Christine E Albers; Devanshika Sapra
Journal:  Cureus       Date:  2022-04-04

3.  Glutamine Breakdown as a Potential Metabolic Biomarker for Nonalcoholic Steatohepatitis.

Authors:  Anna E Garcia Whitlock; Paul M Titchenell
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.